1. Serum hypoxia‐inducible factor‐2: A candidate prognostic biomarker for laryngeal cancer
   Görkem Eskiizmir et al, 2021, Clinical Otolaryngology CrossRef
2. Strong Correlation Between mRNA Expression Levels of HIF-2α, VEGFR1, VEGFR2 and MMP2 in Laryngeal Carcinoma
   Todor M. Popov et al, 2016, Pathology & Oncology Research CrossRef
3. Proangiogenic signature in advanced laryngeal carcinoma after microRNA expression profiling
   T. M. Popov et al, 2020, Molecular Biology Reports CrossRef
4. The Expression of Hypoxia-Related Biomarkers: A Significance of HIF-1α C1772T Polymorphism as Predictor of Laryngeal Carcinoma Relapse
   Miljan M. Folic et al, 2022, Cancer Control CrossRef
5. Research Progress of Hypoxia Inducible Factor-2 in Head and Neck Tumors
   伟 高, 2020, Advances in Clinical Medicine CrossRef
6. Effect of RNAi-Mediated Survivin and Hypoxia-Inducible Factor 1α Gene Silencing on Proliferation, Invasion, Migration and Apoptosis of Gastric Cancer BGC-823 Cells
   Yupeng Li et al, 2023, Molecular Biotechnology CrossRef
7. Proton pump inhibitors and other pH-buffering agents
   Alessio Nocentini et al, 2021, pH-Interfering Agents as Chemosensitizers in Cancer Therapy CrossRef
8. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
   Sophie Taylor et al, 2015, Drug Resistance Updates CrossRef
9. Peritumor Mucosa in Advanced Laryngeal Carcinoma Exhibits an Aberrant Proangiogenic Signature Distinctive from the Expression Pattern in Adjacent Tumor Tissue
   Silva G. Kyurkchiyan et al, 2024, Cells CrossRef